B. Arnold

Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis

G. Gupta, M. Robson, M. Morrow, 2013, Breast Cancer Research and Treatment.

Characteristics and Outcomes of Sentinel Node–Positive Breast Cancer Patients after Total Mastectomy without Axillary-Specific Treatment

H. Cody, M. Morrow, S. Powell, 2012, Annals of Surgical Oncology.

Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.

G. Gupta, Guang Li, B. Mueller, 2019, International journal of radiation oncology, biology, physics.

A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.

M. Lacouture, S. Powell, Zhigang Zhang, 2018, International journal of radiation oncology, biology, physics.

A single-arm, phase II study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).

H. McArthur, C. Barker, Zhigang Zhang, 2018 .

Breast-Conserving Therapy Achieves Locoregional Outcomes Comparable to Mastectomy in Women with T1-2N0 Triple-Negative Breast Cancer

M. Robson, M. Morrow, S. Powell, 2013, Annals of Surgical Oncology.

A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple‐negative breast cancer

H. McArthur, C. Barker, S. Powell, 2019, Cancer.

247PA single-arm, phase ii study assessing the efficacy of pembrolizumab (pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC)

H. McArthur, C. Barker, Y. Wen, 2017 .

A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC).

H. McArthur, C. Barker, Zhigang Zhang, 2018 .